Holdings of WisdomTree BioRevolution Fund
WisdomTree Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 2.3M $ including 2.3M $ in equities, 99.9 %
- Positions
- 84 in 11 countries
- Top ten
- 27.9 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Moderna Inc | 2,024 | 102.8K $ | 4.54 % |
| 2 | Johnson & Johnson | 292 | 71.4K $ | 3.15 % |
| 3 | United Therapeutics Corp | 107 | 63.4K $ | 2.80 % |
| 4 | Pfizer Inc | 2,208 | 62K $ | 2.74 % |
| 5 | Eli Lilly & Co | 65 | 59.8K $ | 2.64 % |
| 6 | Stoke Therapeutics Inc | 1,759 | 57.3K $ | 2.53 % |
| 7 | Natera Inc | 286 | 57.2K $ | 2.53 % |
| 8 | Amgen Inc | 151 | 53.1K $ | 2.35 % |
| 9 | Twist Bioscience Corp | 1,103 | 52.4K $ | 2.32 % |
| 10 | AstraZeneca PLC | 262 | 51.7K $ | 2.28 % |
| 11 | Structure Therapeutics Inc | 1,034 | 49.8K $ | 2.20 % |
| 12 | Amicus Therapeutics Inc | 3,435 | 49.7K $ | 2.19 % |
| 13 | BioNTech SE | 533 | 47.4K $ | 2.09 % |
| 14 | Ionis Pharmaceuticals Inc | 621 | 46.6K $ | 2.06 % |
| 15 | Gilead Sciences Inc | 318 | 44.3K $ | 1.96 % |
| 16 | CRISPR Therapeutics AG | 891 | 42.4K $ | 1.87 % |
| 17 | Immunome Inc | 1,928 | 42.2K $ | 1.86 % |
| 18 | Novonesis Novozymes B | 711 | 41.9K $ | 1.85 % |
| 19 | Beam Therapeutics Inc | 1,726 | 41.1K $ | 1.82 % |
| 20 | 10X Genomics Inc | 1,900 | 40.3K $ | 1.78 % |
| 21 | Darling Ingredients Inc | 622 | 38.5K $ | 1.70 % |
| 22 | Novartis AG | 248 | 37.3K $ | 1.65 % |
| 23 | Roivant Sciences Ltd | 1,307 | 36.2K $ | 1.60 % |
| 24 | Krystal Biotech Inc | 138 | 35.6K $ | 1.57 % |
| 25 | Agios Pharmaceuticals Inc | 1,048 | 35.5K $ | 1.57 % |
| 26 | Bunge Global SA | 274 | 34.9K $ | 1.54 % |
| 27 | Novo Nordisk A/S | 945 | 33.6K $ | 1.49 % |
| 28 | Intellia Therapeutics Inc | 2,622 | 33.6K $ | 1.48 % |
| 29 | Corteva Inc | 392 | 32.8K $ | 1.45 % |
| 30 | Arrowhead Pharmaceuticals Inc | 517 | 32.4K $ | 1.43 % |
| 31 | Vertex Pharmaceuticals Inc | 69 | 30.8K $ | 1.36 % |
| 32 | REGENXBIO Inc | 3,572 | 29.9K $ | 1.32 % |
| 33 | Arcellx Inc | 252 | 28.9K $ | 1.28 % |
| 34 | Allogene Therapeutics Inc | 11,574 | 28.2K $ | 1.25 % |
| 35 | Bristol-Myers Squibb Co | 447 | 27.1K $ | 1.20 % |
| 36 | Takeda Pharmaceutical Co Ltd | 742 | 26.4K $ | 1.17 % |
| 37 | Regeneron Pharmaceuticals, Inc. | 33 | 25.5K $ | 1.13 % |
| 38 | Genmab A/S | 931 | 25K $ | 1.10 % |
| 39 | Verbio SE | 449 | 23.7K $ | 1.05 % |
| 40 | BioMarin Pharmaceutical Inc | 410 | 23.2K $ | 1.02 % |
| 41 | Bayer AG | 506 | 23K $ | 1.01 % |
| 42 | Argenx SE | 29 | 21.2K $ | 0.94 % |
| 43 | Viking Therapeutics Inc | 636 | 20.7K $ | 0.91 % |
| 44 | Veracyte Inc | 637 | 20.5K $ | 0.91 % |
| 45 | Editas Medicine Inc | 8,182 | 20.2K $ | 0.89 % |
| 46 | Danaher Corp | 106 | 20.1K $ | 0.89 % |
| 47 | Arcturus Therapeutics Holdings Inc | 2,494 | 19.3K $ | 0.85 % |
| 48 | Absci Corp | 6,319 | 19K $ | 0.84 % |
| 49 | Iovance Biotherapeutics Inc | 5,273 | 18.5K $ | 0.82 % |
| 50 | Tempus AI Inc | 390 | 17.6K $ | 0.78 % |
| 51 | Merck & Co Inc | 146 | 17.6K $ | 0.78 % |
| 52 | uniQure NV | 1,049 | 17.2K $ | 0.76 % |
| 53 | Repligen Corp | 145 | 17.1K $ | 0.75 % |
| 54 | Biogen Inc | 91 | 16.7K $ | 0.74 % |
| 55 | Exelixis Inc | 377 | 16.2K $ | 0.71 % |
| 56 | Zoetis Inc | 131 | 15.5K $ | 0.68 % |
| 57 | Revolution Medicines Inc | 153 | 14.9K $ | 0.66 % |
| 58 | Sana Biotechnology Inc | 5,002 | 14.4K $ | 0.64 % |
| 59 | Halozyme Therapeutics Inc | 222 | 14.3K $ | 0.63 % |
| 60 | Green Plains Inc | 849 | 14K $ | 0.62 % |
| 61 | Ginkgo Bioworks Holdings Inc | 2,191 | 13.4K $ | 0.59 % |
| 62 | Zealand Pharma A/S | 284 | 12.9K $ | 0.57 % |
| 63 | Bridgebio Pharma Inc | 172 | 12.8K $ | 0.56 % |
| 64 | Syensqo SA | 216 | 12.3K $ | 0.54 % |
| 65 | Geron Corp | 8,007 | 11.9K $ | 0.53 % |
| 66 | Ultragenyx Pharmaceutical Inc | 560 | 11.7K $ | 0.52 % |
| 67 | Genus PLC | 323 | 10.1K $ | 0.45 % |
| 68 | Illumina Inc | 80 | 9.9K $ | 0.44 % |
| 69 | Bio-Techne Corp | 185 | 9.7K $ | 0.43 % |
| 70 | Sarepta Therapeutics Inc | 427 | 9.3K $ | 0.41 % |
| 71 | Schrodinger Inc/United States | 748 | 8.5K $ | 0.38 % |
| 72 | Tyson Foods Inc | 132 | 8.5K $ | 0.37 % |
| 73 | Caribou Biosciences Inc | 4,413 | 8.4K $ | 0.37 % |
| 74 | Alnylam Pharmaceuticals Inc | 25 | 8.3K $ | 0.37 % |
| 75 | Oxford Nanopore Technologies PLC | 5,557 | 8.1K $ | 0.36 % |
| 76 | Recursion Pharmaceuticals Inc | 2,394 | 7.3K $ | 0.32 % |
| 77 | Rocket Pharmaceuticals Inc | 2,033 | 7.3K $ | 0.32 % |
| 78 | Nufarm Ltd | 4,529 | 6.3K $ | 0.28 % |
| 79 | Thermo Fisher Scientific Inc | 12 | 5.9K $ | 0.26 % |
| 80 | Pacific Biosciences of California Inc | 4,371 | 5.8K $ | 0.25 % |
| 81 | QIAGEN NV | 135 | 5.4K $ | 0.24 % |
| 82 | Fate Therapeutics Inc | 4,192 | 5K $ | 0.22 % |
| 83 | FMC Corp | 267 | 4.6K $ | 0.20 % |
| 84 | Biohaven Ltd | 389 | 3.3K $ | 0.15 % |
Sector breakdown
- Health care 41.2 %
- Consumer staples 1.9 %
- Materials 1.5 %
- Unattributed 55.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 89.6 %
- DKK 3.9 %
- EUR 2.6 %
- CHF 1.7 %
- JPY 1.2 %
- GBP 0.8 %
- AUD 0.3 %
The quoted currency of each line, as declared.
Country breakdown
- United States 78.8 %
- Denmark 5.0 %
- Germany 4.2 %
- Switzerland 3.5 %
- United Kingdom 3.1 %
- Netherlands 1.7 %
- Bermuda 1.6 %
- Japan 1.2 %
- Belgium 0.5 %
- Australia 0.3 %
- British Virgin Islands 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 65 | 1.8M $ | 78.77 % |
| 2 | Denmark | 4 | 113.5K $ | 5.02 % |
| 3 | Germany | 3 | 94K $ | 4.16 % |
| 4 | Switzerland | 2 | 79.7K $ | 3.53 % |
| 5 | United Kingdom | 3 | 69.9K $ | 3.09 % |
| 6 | Netherlands | 2 | 38.3K $ | 1.70 % |
| 7 | Bermuda | 1 | 36.2K $ | 1.60 % |
| 8 | Japan | 1 | 26.4K $ | 1.17 % |
| 9 | Belgium | 1 | 12.3K $ | 0.54 % |
| 10 | Australia | 1 | 6.3K $ | 0.28 % |
| 11 | British Virgin Islands | 1 | 3.3K $ | 0.15 % |
Cite this page
Titelia. "Holdings of WisdomTree BioRevolution Fund". https://titelia.com/en/funds/S000071961